Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgical Debulking vs Octreotide LAR in Acromegaly
NCT01371643Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2004
- Primary completion
- Jul 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of octreotide in acromegaly, sponsored by NYU Langone Health. Started Apr 2004; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT01371643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371643.